The Carlyle Group/$CG
About The Carlyle Group
Ticker
Industry
Employees
CG Metrics
$17B
17.65
$2.77
1.69
$1.40
2.86%
Price and volume
Market cap
$17B
Beta
1.69
52-week high
$57.50
52-week low
$36.65
Average daily volume
2.4M
Dividend rate
$1.40
Financial strength
Current ratio
1.746
Quick ratio
1.746
Long term debt to equity
149.605
Total debt to equity
149.605
Management effectiveness
Return on assets (TTM)
4.93%
Return on equity (TTM)
17.99%
Valuation
Price to earnings (TTM)
17.65
Price to revenue (TTM)
3.699
Price to book
2.75
Price to tangible book (TTM)
3.06
Dividend yield (TTM)
2.86%
Forward dividend yield
2.86%
Growth
Revenue change (TTM)
95.78%
Earnings per share change (TTM)
-264.54%
3-year revenue growth (CAGR)
-17.66%
3-year earnings per share growth (CAGR)
-30.36%
3-year dividend per share growth (CAGR)
11.87%
What the Analysts think about CG
Analyst Ratings
CG Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CG Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CG News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE

bluebird bio Stock Alert - Kehoe Law Firm, P.C. Investigating the Fairness and Adequacy of the Proposed Acquisition of bluebird bio by Investment Firms in Collaboration with Biotech Execs

bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
Upcoming events
The Carlyle Group
$0.35
What’s the current market cap for The Carlyle Group stock?
What is the P/E ratio for The Carlyle Group stock?
Does The Carlyle Group stock pay dividends?
Yes, the The Carlyle Group (CG) stock pays dividends to shareholders. As of February 27, 2025, the dividend rate is $1.4 and the yield is 2.86%. The Carlyle Group has a payout ratio of 0% on a trailing twelve-month basis.
When is the next The Carlyle Group dividend payment date?
The next The Carlyle Group (CG) dividend payment is scheduled for February 28, 2025.
What is the beta indicator for The Carlyle Group?
The Carlyle Group (CG) has a beta rating of 1.69. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.